Johnson & Johnson Medical and Changmugu Forge Strategic Partnership to Launch a New Era of AI-Powered Orthopedic Joint Solutions

Original Title: Johnson & Johnson Medical Signs Strategic Cooperation Agreement with Longwood Valley, Unveiling a New Chapter in AI-Empowered Orthopedic Joint Care Source: PR Newswire

SHANGHAI, Nov. 15, 2019 /PRNewswire/ -- On November 15, 2019, at the 21st Academic Conference of Orthopaedics of the Chinese Medical Association and the 14th COA Academic Congress held at the National Exhibition and Convention Center in Shanghai, China, Johnson & Johnson Medical (Shanghai) Ltd. officially signed a cooperation agreement on the "China Orthopedic AI Joint 1.0" project with Beijing Longwood Valley MedTech Co., Ltd., a pioneer in orthopedic artificial intelligence in China. This collaboration, jointly initiated by Johnson & Johnson and Longwood Valley, is an in-depth development project focused on AI-assisted surgical planning in joint surgery. The project aims to transform the extensive surgical expertise of top-tier joint surgery authorities into standardized algorithms for machine deep learning, providing comprehensive AI-based clinical solutions. It seeks to achieve three-dimensional preoperative planning for joint replacement surgeries, enhance surgical precision and standardization, shorten surgeons' learning curves, reduce patients' operative time, and lower the incidence of surgical complications.

Johnson & Johnson Medical and Longwood Valley Strategic Cooperation Signing Ceremony

“This collaboration marks another innovative step by Johnson & Johnson’s Orthopaedics division in the field of digital surgery,” said Chen Min, General Manager of Johnson & Johnson’s Orthopaedics division. “As a global leader in orthopaedics, we are committed to establishing a healthcare environment where patients can access personalized care and interconnected data. Looking ahead, Johnson & Johnson will continue to collaborate with various stakeholders, increasing investment and innovation in areas such as degenerative diseases, minimally invasive orthopaedic procedures, and personalized treatment. We will work hand in hand with governments, regulatory authorities, industry associations, experts, and leading enterprises to jointly explore”Innovative Medical Caresolutions, forging ahead to realize the goals of ‘Healthy China’.”

Dr. Zhang Yiling, CEO of Beijing Longwood Valley MedTech Co., Ltd., expressed strong confidence in this strategic partnership. Dr. Zhang stated, “Longwood Valley is a technology-driven R&D enterprise specializing in artificial intelligence solutions for orthopedics. Leveraging its outstanding innovation and R&D capabilities, the company has been recognized as a National High-Tech Enterprise and”ZhongguancunCertified as a High-Tech Enterprise, its AI products have gained recognition from dozens of top-tier Grade A tertiary hospitals across China. The strategic partnership between Longwood Valley and Johnson & Johnson Medical represents a collaboration between two industry leaders, which will further integrate the “AI HIP – Total Hip Arthroplasty AI-Assisted Planning System” with Johnson & Johnson’s artificial joint systems, helping orthopedic surgeons advance toward “intelligent precision medicine.”

Longwood Valley empowers the entire clinical diagnosis and treatment process in orthopedics with AI, leveraging innovative artificial intelligence technologies to enhance the precision and standardization of orthopedic surgeries. By extending high-quality medical resources to primary care institutions, it improves the overall diagnostic and therapeutic capabilities of grassroots hospitals and young physicians, thereby supporting the implementation of national tiered diagnosis and treatment policies and bringing technological benefits to more patients in China. Johnson & Johnson’s digital surgery strategy aligns closely with Longwood Valley’s mission. In the future, Johnson & Johnson will collaborate with more outstanding innovative enterprises like Longwood Valley to shape the future of healthcare and create value for global healthcare systems.